Clinical correlation of retinal nerve fiber layer thickness in multiple sclerosis patients- A North Indian study

Background: Axonal loss is thought to occur early in the course multiple sclerosis (MS) and is supposed to be associated with, and predictive of, neurologic deficits progressing to permanent disability.Axonal loss in the retinal nerve fiber layer (RNFL) is measured by optical coherence tomography (OCT). Material and Methods: A longitudinal observational study, conducted on 30 MS patients. All subjects underwent neurological examination, including expanded disability status scale (EDSS) scoring and OCT on two visits, minimum 2 months apart. Results: Total of 60 eyes of 30 patients were subdivided into 21 eyes having optic neuritis (ON) [‘MS – ON’] and 39 eyes without ON. The RNFL thickness (RNFLt) was found to be significantly reduced in all parameters except in temporal quadrant, as the duration of disease increases. Average RNFLt were found to have negative correlation (r = -0.450) with disease duration. Negative correlation (r=-0.657) was also found between EDSS score change and average RNFLt change. The eyes having ON showed statistically significant RNFL thinning as compared to the non – ON fellow eyes. The baseline EDSS score was found to be negatively correlated (moderate degree, r = -0.348) with baseline average RNFL thickness, with p-value of 0.006. Conclusions: The RNFLt is not only significantly thinner in those with history of ON, but it is also affected remarkably even in absence of prior ON, suggesting subclinical ongoing axonal loss in patients with MS. The EDSS score is inversely correlated with RNFL thickness.

Functional gait assessment in patients with relapsing-remitting Multiple Sclerosis and relation to the risk of falls / Avaliação funcional da marcha em pacientes com esclerose múltipla recorrenteremitente e relação com o risco de quedas

Objetivo: Demonstrar as avaliações funcionais e sua correlação nos padrões de marcha de pacientes com Esclerose Múltipla, utilizando um método não invasivo por meio do Timed Up and Go, teste de Tinetti, teste de caminhada de 25 pés e escala de Expanded Disability Status Scale (EDSS). Métodos: Foram avaliados 40 pacientes com Esclerose Múltipla, usando Timed Up and Go, teste de Tinetti, teste de caminhada de 25 pés e escala de EDSS. Resultados: No presente estudo, observamos correlações moderadas a altas entre EDSS e Timed Up and Go, teste de Tinetti e teste de caminhada de 25 pés (p < 0,0001). Os pacientes relataram tempos de execução mais longos para os testes Timed Up and Go e 25-Foot Walk e menores escores no teste de Tinetti. Encontramos uma correlação direta entre a duração da doença, a escala EDSS, o tempo de execução Timed Up and Go, o tempo de execução de 25-Foot Walk e o escore do teste de Tinetti (p < 0,0001). Conclusão: avaliações adequadas de risco de marcha e queda são importantes para evitar complicações relacionadas à Esclerose Múltipla. (AU)

Objective: To demonstrate correlation functional evaluations of gait on the patients with Multiple sclerosis, using a noninvasive method by means of Timed Up and Go, Tinetti test, 25-Foot Walk test and Expanded Disability Status Scale (EDSS). Methods: We evaluated 40 patients with Multiple sclerosis using Timed Up and Go, Tinetti test, 25-Foot Walk test and EDSS scale. Results: In present study, we have observed moderate to high correlations between EDSS and Timed Up and Go, Tinetti test and 25-Foot Walk test (p<0.0001). The patients reported longer execution times for Timed Up and Go and 25-Foot Walk tests and lower scores on the Tinetti test. We found a direct correlation between illness duration, EDSS scale, Timed Up and Go execution time, 25-Foot Walk execution time and Tinetti test score (p<0.0001). Conclusion: Proper gait and fall risk evaluations are important in order to avoid complications that are related to Multiple sclerosis. (AU)

Relapsing-remitting multiple sclerosis at remission stage treated with acupuncture:a randomized controlled trial / 中国针灸

<p><b>OBJECTIVE</b>To evaluate the differences in the therapeutic effects on relapsing-remitting multiple sclerosis (RRMS) at remission stage between acupuncture at acupoints and shallow needling therapy at the nearby points.</p><p><b>METHODS</b>Forty-two patients of RRMS were randomized into an observation group and a control group, 21 cases in each one. In the observation group, besides the basic treatment, acupuncture was applied according to's empirical prescriptions as "the empirical ten needles" "thirteen needles of the governor vessel" "twelve needles of hand and foot" as well as the symptomatic points. In the control group, the basic treatment was given. Additionally, the shallow needling therapy was given at the sites 0.2 to 0.3lateral to the acupoints, and the arrival ofwas not required. In the two groups, acupuncture was given once a day for 5 days a week, continuously for 2 weeks. At the intervals of 2 weeks, totally the treatment of 3 months was required. The follow-up visit was conducted for 2 years. Separately, the scores of the expanded disability status scale (EDSS) before and in follow-up after treatment, the annual recurrent rate before and after treatment and recurrent interval after treatment were observed in the patients of the two groups.</p><p><b>RESULTS</b>In the observation group, EDSS scores in 3-month and 6-month follow-up were reduced as compared with those before treatment (both<0.05) and those in the 12-month and 24-month follow-up were increased (both<0.05). In the control group, EDSS scores were increased in tendency continuously in 3-month, 6-month, 12-month and 24-month follow-up (all<0.05). In each time point of follow-up, the different value of EDSS scores in the observation group was lower than that in the control group (<0.05,<0.01). The annual recurrent rates after treatment were reduced as compared with those before treatment in the two groups (both<0.01) and the value in the observation group was lower than that in the control group (<0.01). The recurrent interval in the observation group was longer than that in the control group[(441.56±65.37) d vs (382.78±59.33) d,<0.01].</p><p><b>CONCLUSIONS</b>Acupuncture achieves the significant therapeutic effects on RRMS at the remission stage. This therapy relieves the symptoms of neural functional deficits, delays the time of occurrence and reduces the annual recurrent rate.</p>

Influence of treatment in multiple sclerosis dysability: an open, retrospective, non-randomized long-term analysis / Influência do tratamento na incapacidade da esclerose múltipla: estudo aberto, retrospectivo e não randomizado em longo prazo

The efficacies of immunosuppressive (IMS) and immunomodulatory (IMM) drugs for multiple sclerosis (MS) have been reported in several studies. These agents can reduce relapse rates and lesions observed by magnetic resonance imaging studies. However, the effect of these medications in disability progression over 4 years is rarely examined. OBJECTIVE: To study the disabilities associated with MS patients after a long time period and to analyze the therapeutic influence of different types of treatments in patient disease progression. METHOD: This is an open, uncontrolled, non-randomized, retrospective study of the disease progression using the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Severity Score (MSSS) in 155 cases of MS, which were 76 percent female with a mean age of onset of 30.21±9.70. The follow-up period was 115.39±88.08 months (median 92, 3 to 447 months). These cases were submitted to the following 277 different therapeutic procedures: 62 without IMS or IMM therapy (SYT) (just corticosteroids), 53 with azathioprine (AZA), 53 interferon-β (IFNβ)-1b 250 µg (BET), 55 IFNβ-1a 22 µg (R22), 19 IFNβ-1a 30 µg (AVO), 15 IFNβ-1a 44 µg (R44), 15 glatiramer acetate (COP) 20 mg, and 5 cases with mitoxantrone (MIT). RESULTS: The median EDSS group was 2.00 (0 to 5.5, mean 1.89±1.52) at the onset of each treatment and 2.50 (0 to 9, mean 3.06±2.18) at the end. The median initial MSSS was 3.34 (0.25 to 9.50, mean 3.94±2.91) and the final medial was 3.90 (0.05 to 9.88, mean 4.02±2.78). The EDSS between initial and final score for the whole group had statistically significant progression, as well as for the sub-groups SYT, AZA, BET and R22. No statistically significance difference was found in the MSSS between initial and final scores in the whole group or treatment sub-groups. The variation between the initial and final EDSS and MSSS among the types of treatments found no statistical significance...

A eficácia das medicações imunossupressivas (IMS) e imunomoduladoras (IMM) na esclerose múltipla (MS) tem sido relatada em diversos estudos. Essas medicações podem reduzir o número de surtos e de lesões observadas nos estudos de ressonância magnética. Entretanto, o efeito dessas medicações na progressão da incapacidade em período acima de quatro anos é raramente estudado. OBJETIVO: Estudar a incapacidade associada à MS em longo prazo e analisar os benefícios dos diferentes tipos de tratamento na progressão da doença. MÉTODO: Estudo aberto e retrospectivo da progressão da incapacidade utilizando a escala expandida do grau de incapacidade (EDSS) e o escore da gravidade da esclerose múltipla (MSSS) em 155 casos de MS, sendo 76 por cento do sexo feminino, idade média no início da doença 30,21±9,70 anos e período médio de seguimento 115,39±77,08, mediana 92 (3 a 447) meses. Os casos foram submetidos a 277 tipos diferentes de tratamentos: 62 casos não usaram IMS ou IMM, somente corticosteróides (SYT); 53 com azatioprina (AZA); 53 com interferon-β (IFNβ)-1b 250 µg (BET); 55 com IFNβ-1a 22 µg (R22); 19 com IFNβ-1a 30 µg (AVO); 15 com IFNβ-1a 44 µg (R44); 15 com acetato de glatiramer (COP) 20 mg, e 5 casos com mitoxantrone (MIT). RESULTADOS: A mediana do EDSS do grupo foi 2,0 (0 a 5,5, média total do grupo foi 1,89±1,52) no início de cada tratamento e 2,50 (0 a 9, média de 3,06±2,18) no fim. A mediana inicial da MSSS foi 3,34 (0,25 a 9,50, média 3,94±2,91) e a final 3,90 (0,05 a 9,88, média 4,02±2,78). O EDSS entre o início e o fim do tratamento do grupo mostrou progressão estatisticamente significante e também para os subgrupos SYT, AZA, BET e R22. Não foi encontrada diferença estatística no MSSS entre o início e fim do tratamento no grupo total ou nos subgrupos. Não foi encontrada diferença estatisticamente significante entre a variação inicial e final do EDSS e MSSS entre os diversos subgrupos de tratamento...

Validation of the brazilian version of Guy's neurological disability scale

The Guy's neurological disability scale (GNDS) has recently been introduced as a new measure of disability in multiple sclerosis. It is patient-oriented, multidimensional, and not biased towards any particular disability. The purpose of the present study was to validate the Brazilian version of the GNDS. The adaptation of the scale was based on the translation/back-translation methodology. Sixty-two patients with clinically definite multiple sclerosis (CDMS) according to Poser's criteria were recruited for this study. GNDS was administered individually to each subject. The EDSS and the ambulation index (AI) scores were assigned by a neurologist. The intraclass correlation coefficient and the Cronbach's alpha values of the Brazilian version of GNDS (0.94 and 0.83, respectively) were comparable to the original one (0.98 and 0.79, respectively). Furthermore, the factor analysis of the Brazilian version of GNDS suggested, as the original article, a four-factor solution which accounted for 68.8 percent of the total variance. The Brazilian version of GNDS was found to be clinically relevant as it correlated significantly with the EDSS and AI. In conclusion, the Brazilian version of GNDS can be considered an important tool to evaluate the disability in MS patients, with clinical usefulness and psychometrics soundness.

A Guy's neurological disability scale (GNDS) é uma escala de incapacidade criada recentemente, orientada para o paciente, multidimensional, e que não privilegia nenhum tipo específico de incapacidade. O objetivo deste estudo é validar a GNDS para a língua portuguesa. A adaptação da escala foi feita através do método de tradução e re-tradução. Sessenta e dois pacientes com esclerose múltipla (EM) clinicamente definida de acordo com os critérios de Poser participaram deste estudo. A GNDS foi aplicada individualmente em cada paciente. O EDSS e o índice ambulatorial (IA) foram determinados por neurologista. A correlação intra-classe e o valor de Cronbach's alfa da versão brasileira da GNDS (0.94 e 0.83, respectivamente) foram comparáveis aos do artigo original (0.98 e 0.79, respectivamente). Como no artigo original, a análise fatorial da versão brasileira da GNDS sugeriu uma solução de quatro fatores que explicaria 68.8 por cento da variação total. A versão brasileira da GNDS mostrou-se clinicamente relevante uma vez que se correlacionou com o EDSS e o IA. Em conclusão, a versão brasileira da GNDS pode ser considerada como um importante instrumento de avaliação incapacidade na EM com significado clínico e relevância psicométrica.

Spinal Clinically Isolated Syndromes:Clinical and MRI Analysis / 实用放射学杂志

Objective To evaluate the clinical manifestations and magnetic resonance imaging(MRI) features of the clinically isolated syndrome(CIS) of the spinal cord.Methods MRI features and expanded disability status scale(EDSS) score in 63 patients with multiple sclerosis(MS) showed early clinical manifestations of spinal CIS were retrospectively analysed.Results 52.9% of MS patients in the early performance was the spinal CIS,88.9% was acute or subacute onset,42.9% of the initial symptoms was isolated sensory dysfunction,and 54.9% had cervical spinal cord involvement.The first MRI positive rate was 91.1% and 35.3% presented with "multifocal" plagues.81.7% of the MRI lesions were not more than two vertebral segments,and 89.0% in the axial diameter of the spinal cord did not exceed 1/2.The number,volume and area of MRI lesions at baseline confirmed the positive correlation with EDSS at diagnosis of MS.Corticosteroid therapy before and after the EDSS score was of a significant difference(P= 0.003).Conclusion Spinal CIS often occurs in cervical spinal cord with acute or subacute onset,and incomplete spinal cord injury.MRI may detect "multifocal" plagues.Quantitative MRI is valuable for the assessment of prognosis.Early intravenous corticosteroid therapy can be an effective way to ease symptoms.